Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalie Hoog-Labouret

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Therapie|December 6, 2003
Methodology for the evaluation of drugs in pregnant womenMarina Chauvenet, Alain Rimailho, Natalie Hoog-Labouret
Therapie|November 24, 2004
Methodology for small clinical trialsMuriel Vray, Danièle Girault, Natalie Hoog-Labouret, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 14, 2018
Fertility preservation and cancer: How many persons are concerned?Christine Le Bihan-Benjamin, Natalie Hoog-Labouret, Delphine Lefeuvre, et al.
Nature Reviews. Clinical Oncology|March 23, 2016
Equal access to innovative therapies and precision cancer careAgnès Buzyn, Jean-Yves Blay, Natalie Hoog-Labouret, et al.
Journal of Medical Case Reports|July 26, 2019
Persistent response to vemurafenib in metastatic ameloblastoma with BRAF mutation: a case reportMorgane Broudic-Guibert, Jean-Yves Blay, Léa Vazquez, et al.
Therapie|February 18, 2020
Michel Cucherat, Silvy Laporte, Olivier Delaitre, et al.
Therapie|February 18, 2020
From single-arm studies to externally controlled studies. Methodological considerations and guidelinesMichel Cucherat, Silvy Laporte, Olivier Delaitre, et al.
Therapie|July 10, 2016
[Not Available]Pierre Marquet, Pierre-Henry Longeray, Fabrice Barlesi, et al.
Therapie|February 14, 2015
Translational research: precision medicine, personalized medicine, targeted therapies: marketing or science?Pierre Marquet, Pierre-Henry Longeray, Fabrice Barlesi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 17, 2024
Precision cancer medicine platform trials: Concepts and design of AcSé-ESMARTBirgit Geoerger, Francisco Bautista, Nicolas André, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Therapie|December 6, 2003
Methodology for the evaluation of drugs in pregnant womenMarina Chauvenet, Alain Rimailho, Natalie Hoog-Labouret
Therapie|November 24, 2004
Methodology for small clinical trialsMuriel Vray, Danièle Girault, Natalie Hoog-Labouret, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 14, 2018
Fertility preservation and cancer: How many persons are concerned?Christine Le Bihan-Benjamin, Natalie Hoog-Labouret, Delphine Lefeuvre, et al.
Nature Reviews. Clinical Oncology|March 23, 2016
Equal access to innovative therapies and precision cancer careAgnès Buzyn, Jean-Yves Blay, Natalie Hoog-Labouret, et al.
Journal of Medical Case Reports|July 26, 2019
Persistent response to vemurafenib in metastatic ameloblastoma with BRAF mutation: a case reportMorgane Broudic-Guibert, Jean-Yves Blay, Léa Vazquez, et al.
Therapie|February 18, 2020
Michel Cucherat, Silvy Laporte, Olivier Delaitre, et al.
Therapie|February 18, 2020
From single-arm studies to externally controlled studies. Methodological considerations and guidelinesMichel Cucherat, Silvy Laporte, Olivier Delaitre, et al.
Therapie|July 10, 2016
[Not Available]Pierre Marquet, Pierre-Henry Longeray, Fabrice Barlesi, et al.
Therapie|February 14, 2015
Translational research: precision medicine, personalized medicine, targeted therapies: marketing or science?Pierre Marquet, Pierre-Henry Longeray, Fabrice Barlesi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 17, 2024
Precision cancer medicine platform trials: Concepts and design of AcSé-ESMARTBirgit Geoerger, Francisco Bautista, Nicolas André, et al.
Pageof 2